An overview and update of ATP7A mutations leading to menkes disease and occipital horn syndrome

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

An overview and update of ATP7A mutations leading to menkes disease and occipital horn syndrome. / Tümer, Zeynep.

In: Human Mutation, Vol. 34, No. 3, 03.2013, p. 417-29.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Tümer, Z 2013, 'An overview and update of ATP7A mutations leading to menkes disease and occipital horn syndrome', Human Mutation, vol. 34, no. 3, pp. 417-29. https://doi.org/10.1002/humu.22266

APA

Tümer, Z. (2013). An overview and update of ATP7A mutations leading to menkes disease and occipital horn syndrome. Human Mutation, 34(3), 417-29. https://doi.org/10.1002/humu.22266

Vancouver

Tümer Z. An overview and update of ATP7A mutations leading to menkes disease and occipital horn syndrome. Human Mutation. 2013 Mar;34(3):417-29. https://doi.org/10.1002/humu.22266

Author

Tümer, Zeynep. / An overview and update of ATP7A mutations leading to menkes disease and occipital horn syndrome. In: Human Mutation. 2013 ; Vol. 34, No. 3. pp. 417-29.

Bibtex

@article{79f87102ee564d15b89c707579eedab0,
title = "An overview and update of ATP7A mutations leading to menkes disease and occipital horn syndrome",
abstract = "Menkes disease (MD) is a lethal multisystemic disorder of copper metabolism. Progressive neurodegeneration and connective tissue disturbances, together with the peculiar {"}kinky{"} hair, are the main manifestations. MD is inherited as an X-linked recessive trait, and as expected the vast majority of patients are males. MD occurs because of mutations in the ATP7A gene and the vast majority of ATP7A mutations are intragenic mutations or partial gene deletions. ATP7A is an energy-dependent transmembrane protein, which is involved in the delivery of copper to the secreted copper enzymes and in the export of surplus copper from cells. Severely affected MD patients die usually before the third year of life. A cure for the disease does not exist, but very early copper-histidine treatment may correct some of the neurological symptoms. This study reviews 274 published and 18 novel disease causing mutations identified in 370 unrelated MD patients, nonpathogenic variants of ATP7A, functional studies of the ATP7A mutations, and animal models of MD.",
author = "Zeynep T{\"u}mer",
note = "{\textcopyright} 2012 Wiley Periodicals, Inc.",
year = "2013",
month = mar,
doi = "10.1002/humu.22266",
language = "English",
volume = "34",
pages = "417--29",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "JohnWiley & Sons, Inc.",
number = "3",

}

RIS

TY - JOUR

T1 - An overview and update of ATP7A mutations leading to menkes disease and occipital horn syndrome

AU - Tümer, Zeynep

N1 - © 2012 Wiley Periodicals, Inc.

PY - 2013/3

Y1 - 2013/3

N2 - Menkes disease (MD) is a lethal multisystemic disorder of copper metabolism. Progressive neurodegeneration and connective tissue disturbances, together with the peculiar "kinky" hair, are the main manifestations. MD is inherited as an X-linked recessive trait, and as expected the vast majority of patients are males. MD occurs because of mutations in the ATP7A gene and the vast majority of ATP7A mutations are intragenic mutations or partial gene deletions. ATP7A is an energy-dependent transmembrane protein, which is involved in the delivery of copper to the secreted copper enzymes and in the export of surplus copper from cells. Severely affected MD patients die usually before the third year of life. A cure for the disease does not exist, but very early copper-histidine treatment may correct some of the neurological symptoms. This study reviews 274 published and 18 novel disease causing mutations identified in 370 unrelated MD patients, nonpathogenic variants of ATP7A, functional studies of the ATP7A mutations, and animal models of MD.

AB - Menkes disease (MD) is a lethal multisystemic disorder of copper metabolism. Progressive neurodegeneration and connective tissue disturbances, together with the peculiar "kinky" hair, are the main manifestations. MD is inherited as an X-linked recessive trait, and as expected the vast majority of patients are males. MD occurs because of mutations in the ATP7A gene and the vast majority of ATP7A mutations are intragenic mutations or partial gene deletions. ATP7A is an energy-dependent transmembrane protein, which is involved in the delivery of copper to the secreted copper enzymes and in the export of surplus copper from cells. Severely affected MD patients die usually before the third year of life. A cure for the disease does not exist, but very early copper-histidine treatment may correct some of the neurological symptoms. This study reviews 274 published and 18 novel disease causing mutations identified in 370 unrelated MD patients, nonpathogenic variants of ATP7A, functional studies of the ATP7A mutations, and animal models of MD.

U2 - 10.1002/humu.22266

DO - 10.1002/humu.22266

M3 - Journal article

C2 - 23281160

VL - 34

SP - 417

EP - 429

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 3

ER -

ID: 47713591